New Resource: Comprehensive Review of 2024 Afirma Research Now Available
Download
Breakthroughs in endocrinology research
Leading endocrinology experts continue to utilize Afirma® GSC in rigorous research.
  • Positive Predictive Value of NTRK, RET, BRAF, and ALK Fusions in Bethesda III/IV Thyroid Fine-Needle Aspirates

    November 2019
  • NTRK, RET, BRAF, and ALK Fusions in Thyroid Fine-Needle Aspirates (FNAs)

    November 2019
  • Identification of Rare, Canonically Mutually Exclusive Variants in Thyroid FNAs

    November 2019
  • Extending expressed RNA genomics from surgical decision making for cytologically indeterminate thyroid nodules to targeting therapies for MTC

    November 2019
  • Interview with Gregory Randolph, M.D: Clinical Validation of the Afirma Genomic Sequencing Classifier for Medullary Thyroid Cancer

    Oct 2017
  • Interview with Richard Kloos, MD: Clinical Validation of the Afirma Genomic Sequencing Parathyroid Classifier

    Oct 2017
  • Interview with Trevor Angell, MD: Clinical Validation of the Afirma Genomic Sequencing BRAF V600E Classifier

    Oct 2017